June 26 (Reuters) – Unilever is exploring a bid for Thorne, a U.S. supplements maker valued at up to $4 billion, the Financial Times reported on Friday. Reuters could not immediately verify the report
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)